Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 6 | Journal for ImmunoTherapy of Cancer

Fig. 6

From: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Fig. 6

Percentages of total population of patients (all; n = 162) or of patients at each histological grade (G1; n = 4, G2; n = 86,G3; n = 72); T status (T1; n = 70, T2; n = 81,T3; n = 10); node status (N0; n = 64, N1-3; n = 56, N > 3; n = 42) and pathological stage (stage I; n = 45, stage II; n = 72, stage III; n = 45) expressing FCIS or UCIS or rest (“rest” includes HH/HH; LL/LL; HH/LL and LL/HH)

Back to article page